"Preeclampsia not only affects maternal health but can also significantly impact fetal and neonatal short- and long-term ...

Engineers at the University of Pennsylvania made a critical breakthrough that is should help cure pregnancies threatened with ...

Engineers have developed a lipid nanoparticle (LNP) that delivers mRNA therapeutic to the placenta to treat pre-eclampsia in mice with human trials on the horizon.

While Tsigas says all of the causes or contributing factors related to preeclampsia are not fully understood, "but there is general agreement that the placenta plays a key role - and women with ...

The pathophysiology of pre-eclampsia is complex and involves various pathways and mechanisms that are interlinked. There is ongoing research to help us further understand this condition and try to ...

Researchers at the University of Pennsylvania are testing a novel treatment using mRNA—the same technology behind COVID-19 ...

Preeclampsia arises due to insufficient blood flow to the placenta, which causes a mom’s blood pressure to rise while restricting blood flow to the fetus. Researchers figured that a drug designed to ...

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of preeclampsia, according to a study in ...

Hojo M, August P. Calcium Metabolism in Preeclampsia: Supplementation May Help. MedGenMed 1(2), 1999. [formerly published in Medscape Women's Health eJournal 2(1), 1997]. Available at: https ...

Pre-eclampsia occurs in 3–5% of all pregnancies and is responsible for half a million infant deaths each year. The placenta is crucial for exchanging nutrients, oxygen and waste between the foetus and ...